Pharvaris N.V. PHVS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Pharvaris N.V. is a biopharmaceutical company that specializes in discovering, developing, and commercializing innovative therapies to treat hereditary angioedema (HAE) and other bradykinin B2 receptor-mediated diseases. With its headquarters in Leiden, the Netherlands, Pharvaris is prominently focused on addressing un…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountrySwitzerland
Employees108
TickerPHVS
Statistics
Market Cap$2.15B
Revenue (TTM)$0
Net Income-$175.7M
Net Margin—
EPS$-3.13
P/E-10.86
P/S—
P/B7.52
EV/EBITDA-10.60
ROE-73.0%
Dividend Yield—
Price$32.88
Data: Twelve Data · Revenue = mcap / P/S